In House HSV PCR, Process Improvement and Cost Effectiveness Analysis
Herpes Simples Virus (HSV) is an etiologic agent of serious central nervous system (CNS) infections in both adults and children. HSV encephalitis has a worldwide incidence of about 500,000 persons per year with an overall mortality rate of 11-19 percent with treatment. Maternal HSV infection may res...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Report |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Carr,Nicholas R Weber,Zachary J Sutter,Deena E |
| description | Herpes Simples Virus (HSV) is an etiologic agent of serious central nervous system (CNS) infections in both adults and children. HSV encephalitis has a worldwide incidence of about 500,000 persons per year with an overall mortality rate of 11-19 percent with treatment. Maternal HSV infection may result in neonatal disease, to include disseminated skin eye and mucous membrane (SEM) and CNS infection. Neonatal HSV infections occur approximately in 1 in 3000 to 20,000 lives births with 1500 cases reported annually with 29% mortality with aggressive treatment.
American Academy of Pediatrics (AAP) National Conference and Exhibition, , 15 Sep 2017, 19 Sep 2017, |
| format | Report |
| fullrecord | <record><control><sourceid>dtic_1RU</sourceid><recordid>TN_cdi_dtic_stinet_AD1040568</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AD1040568</sourcerecordid><originalsourceid>FETCH-dtic_stinet_AD10405683</originalsourceid><addsrcrecordid>eNrjZHD1zFPwyC8tTlXwCA5TCHAO0lEIKMpPTi0uVvDMLSjKL0vNTc0rUUjMS1Fwzi8uUXBNS0tNLsksS80DKXHMS8ypLM4s5mFgTUvMKU7lhdLcDDJuriHOHropJZnJ8cUlmXmpJfGOLoYGJgamZhbGBKQBNjou4g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype></control><display><type>report</type><title>In House HSV PCR, Process Improvement and Cost Effectiveness Analysis</title><source>DTIC Technical Reports</source><creator>Carr,Nicholas R ; Weber,Zachary J ; Sutter,Deena E</creator><creatorcontrib>Carr,Nicholas R ; Weber,Zachary J ; Sutter,Deena E ; 59th Medical Wing San Antonio United States</creatorcontrib><description>Herpes Simples Virus (HSV) is an etiologic agent of serious central nervous system (CNS) infections in both adults and children. HSV encephalitis has a worldwide incidence of about 500,000 persons per year with an overall mortality rate of 11-19 percent with treatment. Maternal HSV infection may result in neonatal disease, to include disseminated skin eye and mucous membrane (SEM) and CNS infection. Neonatal HSV infections occur approximately in 1 in 3000 to 20,000 lives births with 1500 cases reported annually with 29% mortality with aggressive treatment.
American Academy of Pediatrics (AAP) National Conference and Exhibition, , 15 Sep 2017, 19 Sep 2017,</description><language>eng</language><subject>CNS(CENTRAL NERVOUS SYSTEM) ; COST ANALYSIS ; COST EFFECTIVENESS ; DELIVERY OF HEALTH CARE ; DRUG THERAPY ; ENCEPHALITIS ; Herpes simplex virus ; HOSPITALIZATIONS ; HSV(HERPES SIMPLEX VIRUS) ; INFANTS ; Medicine and Medical Research ; Microbiology ; PCR(Polymerase chain reaction) ; PEDIATRICS</subject><creationdate>2017</creationdate><rights>Approved For Public Release</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,780,885,27567,27568</link.rule.ids><linktorsrc>$$Uhttps://apps.dtic.mil/sti/citations/AD1040568$$EView_record_in_DTIC$$FView_record_in_$$GDTIC$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Carr,Nicholas R</creatorcontrib><creatorcontrib>Weber,Zachary J</creatorcontrib><creatorcontrib>Sutter,Deena E</creatorcontrib><creatorcontrib>59th Medical Wing San Antonio United States</creatorcontrib><title>In House HSV PCR, Process Improvement and Cost Effectiveness Analysis</title><description>Herpes Simples Virus (HSV) is an etiologic agent of serious central nervous system (CNS) infections in both adults and children. HSV encephalitis has a worldwide incidence of about 500,000 persons per year with an overall mortality rate of 11-19 percent with treatment. Maternal HSV infection may result in neonatal disease, to include disseminated skin eye and mucous membrane (SEM) and CNS infection. Neonatal HSV infections occur approximately in 1 in 3000 to 20,000 lives births with 1500 cases reported annually with 29% mortality with aggressive treatment.
American Academy of Pediatrics (AAP) National Conference and Exhibition, , 15 Sep 2017, 19 Sep 2017,</description><subject>CNS(CENTRAL NERVOUS SYSTEM)</subject><subject>COST ANALYSIS</subject><subject>COST EFFECTIVENESS</subject><subject>DELIVERY OF HEALTH CARE</subject><subject>DRUG THERAPY</subject><subject>ENCEPHALITIS</subject><subject>Herpes simplex virus</subject><subject>HOSPITALIZATIONS</subject><subject>HSV(HERPES SIMPLEX VIRUS)</subject><subject>INFANTS</subject><subject>Medicine and Medical Research</subject><subject>Microbiology</subject><subject>PCR(Polymerase chain reaction)</subject><subject>PEDIATRICS</subject><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2017</creationdate><recordtype>report</recordtype><sourceid>1RU</sourceid><recordid>eNrjZHD1zFPwyC8tTlXwCA5TCHAO0lEIKMpPTi0uVvDMLSjKL0vNTc0rUUjMS1Fwzi8uUXBNS0tNLsksS80DKXHMS8ypLM4s5mFgTUvMKU7lhdLcDDJuriHOHropJZnJ8cUlmXmpJfGOLoYGJgamZhbGBKQBNjou4g</recordid><startdate>20170915</startdate><enddate>20170915</enddate><creator>Carr,Nicholas R</creator><creator>Weber,Zachary J</creator><creator>Sutter,Deena E</creator><scope>1RU</scope><scope>BHM</scope></search><sort><creationdate>20170915</creationdate><title>In House HSV PCR, Process Improvement and Cost Effectiveness Analysis</title><author>Carr,Nicholas R ; Weber,Zachary J ; Sutter,Deena E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-dtic_stinet_AD10405683</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2017</creationdate><topic>CNS(CENTRAL NERVOUS SYSTEM)</topic><topic>COST ANALYSIS</topic><topic>COST EFFECTIVENESS</topic><topic>DELIVERY OF HEALTH CARE</topic><topic>DRUG THERAPY</topic><topic>ENCEPHALITIS</topic><topic>Herpes simplex virus</topic><topic>HOSPITALIZATIONS</topic><topic>HSV(HERPES SIMPLEX VIRUS)</topic><topic>INFANTS</topic><topic>Medicine and Medical Research</topic><topic>Microbiology</topic><topic>PCR(Polymerase chain reaction)</topic><topic>PEDIATRICS</topic><toplevel>online_resources</toplevel><creatorcontrib>Carr,Nicholas R</creatorcontrib><creatorcontrib>Weber,Zachary J</creatorcontrib><creatorcontrib>Sutter,Deena E</creatorcontrib><creatorcontrib>59th Medical Wing San Antonio United States</creatorcontrib><collection>DTIC Technical Reports</collection><collection>DTIC STINET</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Carr,Nicholas R</au><au>Weber,Zachary J</au><au>Sutter,Deena E</au><aucorp>59th Medical Wing San Antonio United States</aucorp><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><btitle>In House HSV PCR, Process Improvement and Cost Effectiveness Analysis</btitle><date>2017-09-15</date><risdate>2017</risdate><abstract>Herpes Simples Virus (HSV) is an etiologic agent of serious central nervous system (CNS) infections in both adults and children. HSV encephalitis has a worldwide incidence of about 500,000 persons per year with an overall mortality rate of 11-19 percent with treatment. Maternal HSV infection may result in neonatal disease, to include disseminated skin eye and mucous membrane (SEM) and CNS infection. Neonatal HSV infections occur approximately in 1 in 3000 to 20,000 lives births with 1500 cases reported annually with 29% mortality with aggressive treatment.
American Academy of Pediatrics (AAP) National Conference and Exhibition, , 15 Sep 2017, 19 Sep 2017,</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_dtic_stinet_AD1040568 |
| source | DTIC Technical Reports |
| subjects | CNS(CENTRAL NERVOUS SYSTEM) COST ANALYSIS COST EFFECTIVENESS DELIVERY OF HEALTH CARE DRUG THERAPY ENCEPHALITIS Herpes simplex virus HOSPITALIZATIONS HSV(HERPES SIMPLEX VIRUS) INFANTS Medicine and Medical Research Microbiology PCR(Polymerase chain reaction) PEDIATRICS |
| title | In House HSV PCR, Process Improvement and Cost Effectiveness Analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T07%3A01%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-dtic_1RU&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.btitle=In%20House%20HSV%20PCR,%20Process%20Improvement%20and%20Cost%20Effectiveness%20Analysis&rft.au=Carr,Nicholas%20R&rft.aucorp=59th%20Medical%20Wing%20San%20Antonio%20United%20States&rft.date=2017-09-15&rft_id=info:doi/&rft_dat=%3Cdtic_1RU%3EAD1040568%3C/dtic_1RU%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |